Patents/Assignees

Dicerna Pharmaceuticals, Inc.

27 patents in portfolio

US12564601utility2026
Methods for Treating Hepatitis B Infection
0 cites
US12435336utility2025
Compositions and Methods for Inhibiting LPA Expression
0 cites
US12252691utility2025
Compositions and Methods for Inhibiting LPA Expression
0 cites
US12234456utility2025
Compositions and Methods for Modulating APOC3 Expression
0 cites
US12084662utility2024
Compositions and Methods for Modulating PNPLA3 Expression
0 cites
US12077756utility2024
Extended Dicer Substrate Agents and Methods for the Specific Inhibition of Gene Expression
0 cites
US12037358utility2024
Compositions Comprising Reversibly Modified Oligonucleotides and Uses Thereof
0 cites
US12037586utility2024
4′-phosphate Analogs and Oligonucleotides Comprising the Same
0 cites
US11952574utility2024
Compositions and Methods for Inhibiting Transmembrane Serine Protease 6 (TMPRSS6) Expression
0 cites
US11912996utility2024
Methods and Compositions for the Specific Inhibition of Alpha-1 Antitrypsin by Double-stranded RNA
0 cites
US11873488utility2024
Double-stranded Nucleic Acid Inhibitor Molecules Modified with Tm-increasing Nucleotides
0 cites
US11873493utility2024
Methods and Compositions for the Specific Inhibition of Glycolate Oxidase (HAO1) by Double-stranded RNA
0 cites
US11851658utility2023
Methods and Compositions for the Specific Inhibition of Alpha-1 Antitrypsin by Double-stranded RNA
0 cites
US11813280utility2023
Reducing Beta-catenin and IDO Expression to Potentiate Immunotherapy
0 cites
US11773390utility2023
Methods and Compositions for the Specific Inhibition of Complement Component 5(C5) by Double-stranded RNA
0 cites
US11697812utility2023
Methods and Compositions for the Specific Inhibition of Transthyretin (TTR) by Double-stranded RNA
0 cites
US11667918utility2023
Methods and Compositions for the Specific Inhibition of Antithrombin 3 (AT3) by Double-stranded RNA
0 cites
US11661603utility2023
Compositions and Methods for Inhibiting ALDH2 Expression
0 cites
US11661604utility2023
Methods and Compositions for Inhibiting Expression of LDHA
0 cites
US11655473utility2023
Compositions and Methods for Inhibiting Mitochondria Amidoxime Reducing Component 1 (MARC1) Expression
0 cites

Page 1 of 2Next →